
Aliivosidenib
Generic Name:Ivosidenib
Specification:250mg × 60 ເມັດ
Oncology & Hematology
View DetailsProduct information and authorised purchase channels
Epico Pharmaceutical-Health Products Industries Co., Ltd., based in Vientiane, Laos, operates across the full pharmaceutical chain - research and development, manufacturing, sales, and import and export trade - with a core focus on medicines tailored to Laos, especially targeted anticancer drugs. In March 2026, the company obtained all three licences from the Lao Ministry of Health: pharmaceutical manufacturing, distribution, and import and export. It operates a 1,600 sq.m pharmaceutical warehouse in Vientiane, and its new office building came into operation in November 2026. The company works closely with the Lao Pharmaceutical Factory No. 3, with the first export shipment in May 2026; in August 2026 it entered full cooperation with the Pharmaceutical Factory No. 104 of the Ministry of National Defence, and is developing pharmaceutical and tourism integrated scenarios.

Generic Name:Ivosidenib
Specification:250mg × 60 ເມັດ
Oncology & Hematology
View Details
Generic Name:Olaparib
Specification:150mg × 120 ເມັດ
Oncology & Hematology
View Details
Generic Name:Osimertinib
Specification:80mg × 30 ເມັດ
Oncology & Hematology
View Details
Generic Name:Dabrafenib
Specification:75mg × 120 ແຄບຊູນ
Oncology & Hematology
View Details
Generic Name:Cabozantinib
Specification:20mg × 90 ແຄບຊູນ
Oncology & Hematology
View Details
Generic Name:Cabozantinib
Specification:20mg × 90 ເມັດ
Oncology & Hematology
View DetailsAuthorised pharmacies and distributors
Information only — no online sales · Disclaimer & Terms